As of Aug 21
| -0.0168 / -1.77%|
The 3 analysts offering 12-month price forecasts for Intellipharmaceutics International Inc have a median target of 2.00, with a high estimate of 7.30 and a low estimate of 1.00. The median estimate represents a +114.32% increase from the last price of 0.93.
The current consensus among 3 polled investment analysts is to Buy stock in Intellipharmaceutics International Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.